Ekso Bionics Reports Fourth Quarter and Year End 2022 Results
Revenue in the fourth quarter of 2022 included approximately $3.5 million in EksoHealth revenue and approximately $0.1 million in EksoWorks revenue.
- Revenue in the fourth quarter of 2022 included approximately $3.5 million in EksoHealth revenue and approximately $0.1 million in EksoWorks revenue.
- The Company booked a total of 27 EksoHealth devices in the fourth quarter of 2022.
- Sales and marketing expenses for the quarter ended December 31, 2022 were $1.9 million, compared to $2.0 million for the same period in 2021.
- Research and development expenses for the quarter ended December 31, 2022 were $0.9 million, compared to $0.8 million for the same period in 2021.